In 2023, Samsung Biologics posted a net profit of around 857.7 billion South Korean won. Samsung Biologics is a pharmaceutical company of Samsung Group and produces biopharmaceuticals for global companies. Biotech and health sector are among the key growth engine industries of Samsung Group.
Net profit of Samsung Biologics from 2015 to 2023
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DART. (March 7, 2024). Net profit of Samsung Biologics from 2015 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. "Net profit of Samsung Biologics from 2015 to 2023 (in billion South Korean won)." Chart. March 7, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. (2024). Net profit of Samsung Biologics from 2015 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. "Net Profit of Samsung Biologics from 2015 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 7 Mar 2024, https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART, Net profit of Samsung Biologics from 2015 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/ (last visited December 22, 2024)
Net profit of Samsung Biologics from 2015 to 2023 (in billion South Korean won) [Graph], DART, March 7, 2024. [Online]. Available: https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
